Drug Profile
HUP 13
Latest Information Update: 21 Apr 2022
Price :
$50
*
At a glance
- Originator Shanghai Institute of Materia Medica
- Class Antidementias; Neuroprotectants
- Mechanism of Action Acetylcholinesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cognition disorders
Most Recent Events
- 21 Apr 2022 Discontinued - Preclinical for Cognition disorders in China (unspecified route)
- 30 May 2001 Profile reviewed but no significant changes made
- 21 Jan 1997 No-Development-Reported for Cognition disorders in China (Unknown route)